Perlmutter Cancer Center at New York University Langone Hospital - Long Island is a clinical research site located in New York, New York, United States 10016.
Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.
Perlmutter Cancer Center at New York University Langone Hospital - Long Island has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Limited Stage Small Cell Lung Cancer, Small Cell Lung Cancer.
Sponsors: Amgen.
Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Perlmutter Cancer Center at New York University Langone Hospital - Long Island has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Perlmutter Cancer Center at New York University Langone Hospital - Long Island has 1 clinical trials on record, with 1 currently active. Their work covers Limited Stage Small Cell Lung Cancer, Small Cell Lung Cancer.
Perlmutter Cancer Center at New York University Langone Hospital - Long Island has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.